Mukherjee Mana Mohan, Bond Michelle R, Abramowitz Lara K, Biesbrock Devin, Woodroofe Carolyn C, Kim Eun Ju, Swenson Rolf E, Hanover John A
Laboratory of Cell and Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States.
Frederick National Laboratory for Cancer Research, National Cancer Institute, Fredrick, MD, United States.
Front Mol Biosci. 2023 Dec 7;10:1286690. doi: 10.3389/fmolb.2023.1286690. eCollection 2023.
Metabolic chemical reporters (MCRs) provide easily accessible means to study glycans in their native environments. However, because monosaccharide precursors are shared by many glycosylation pathways, selective incorporation has been difficult to attain. Here, a strategy for defining the selectivity and enzymatic incorporation of an MCR is presented. Performing β-elimination to interrogate -linked sugars and using commercially available glycosidases and glycosyltransferase inhibitors, we probed the specificity of widely used azide (AcGalNAz) and alkyne (AcGalNAlk and AcGlcNAlk) sugar derivatives. Following the outlined strategy, we provide a semiquantitative assessment of the specific and non-specific incorporation of this bioorthogonal sugar (AcGalNAz) into numerous - and -linked glycosylation pathways. This approach should be generally applicable to other MCRs to define the extent of incorporation into the various glycan species.
代谢化学报告分子(MCRs)为在天然环境中研究聚糖提供了易于获取的手段。然而,由于单糖前体被许多糖基化途径共享,因此难以实现选择性掺入。在此,我们提出了一种定义MCR选择性和酶促掺入的策略。通过进行β-消除反应来探究连接的糖,并使用市售的糖苷酶和糖基转移酶抑制剂,我们研究了广泛使用的叠氮化物(AcGalNAz)和炔烃(AcGalNAlk和AcGlcNAlk)糖衍生物的特异性。按照所概述的策略,我们对半定量评估了这种生物正交糖(AcGalNAz)在众多连接和连接的糖基化途径中的特异性和非特异性掺入情况。这种方法通常应适用于其他MCR,以确定其掺入各种聚糖种类的程度。